The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Metrorrhagia


High impact information on Metrorrhagia


Chemical compound and disease context of Metrorrhagia


Biological context of Metrorrhagia


Anatomical context of Metrorrhagia


Gene context of Metrorrhagia


Analytical, diagnostic and therapeutic context of Metrorrhagia


  1. Relationship between circulating estradiol levels, body mass index, and breakthrough bleeding in postmenopausal women receiving hormone replacement therapy. Büyük, E., Gürler, A., Erenus, M. Menopause (New York, N.Y.) (1998) [Pubmed]
  2. Long-lasting remission and successful treatment of acquired factor VIII inhibitors using cyclophosphamide in a patient with systemic lupus erythematosus. Trotta, F., Bajocchi, G., La Corte, R., Moratelli, S., Sun, L.Y. Rheumatology (Oxford, England) (1999) [Pubmed]
  3. Depot goserelin and danazol pre-treatment before rollerball endometrial ablation for menorrhagia. Fraser, I.S., Healy, D.L., Torode, H., Song, J.Y., Mamers, P., Wilde, F. Obstetrics and gynecology. (1996) [Pubmed]
  4. Efficacy of mefenamic acid in patients with a complaint of menorrhagia. Fraser, I.S., Pearse, C., Shearman, R.P., Elliott, P.M., McIlveen, J., Markham, R. Obstetrics and gynecology. (1981) [Pubmed]
  5. Uterine artery blood flow parameters in women with dysfunctional uterine bleeding and uterine fibroids: the effects of tranexamic acid. Lakhani, K.P., Marsh, M.S., Purcell, W., Hardiman, P. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. (1998) [Pubmed]
  6. Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive. Saano, V., Glue, P., Banfield, C.R., Reidenberg, P., Colucci, R.D., Meehan, J.W., Haring, P., Radwanski, E., Nomeir, A., Lin, C.C. Clin. Pharmacol. Ther. (1995) [Pubmed]
  7. Steroidogenesis in an estrogen-producing adrenal tumor in a young woman: comparison with steroid profiles associated with cortisol- and androgen-producing tumors. McKenna, T.J., O'Connell, Y., Cunningham, S., McCabe, M., Culliton, M. J. Clin. Endocrinol. Metab. (1990) [Pubmed]
  8. Impaired estrogen-induced luteinizing hormone release in young women with anovulatory dysfunctional uterine bleeding. Van Look, P.F., Hunter, W.M., Fraser, I.S., Baird, D.T. J. Clin. Endocrinol. Metab. (1978) [Pubmed]
  9. Low-dose ethinylestradiol/levonorgestrel. Dando, T.M., Curran, M.P. Drugs (2005) [Pubmed]
  10. Plasma cells in chronic endometritis are easily identified when stained with syndecan-1. Bayer-Garner, I.B., Korourian, S. Mod. Pathol. (2001) [Pubmed]
  11. Tranexamic acid: a review of its use in the management of menorrhagia. Wellington, K., Wagstaff, A.J. Drugs (2003) [Pubmed]
  12. Goserelin acetate (Zoladex) plus endometrial ablation for dysfunctional uterine bleeding: a large randomized, double-blind study. Donnez, J., Vilos, G., Gannon, M.J., Stampe-Sorensen, S., Klinte, I., Miller, R.M. Fertil. Steril. (1997) [Pubmed]
  13. Antiprogestins as a model for progesterone withdrawal. Critchley, H.O., Kelly, R.W., Brenner, R.M., Baird, D.T. Steroids (2003) [Pubmed]
  14. Endothelial cell dysfunction following prolonged activation of progesterone receptor. Rodríguez-Manzaneque, J.C., Graubert, M., Iruela-Arispe, M.L. Hum. Reprod. (2000) [Pubmed]
  15. A prospective 1-year study of estrogen and progestin in postmenopausal women: effects on the endometrium. Gelfand, M.M., Ferenczy, A. Obstetrics and gynecology. (1989) [Pubmed]
  16. Endometrial blood flow measured by xenon 133 clearance in women with normal menstrual cycles and dysfunctional uterine bleeding. Fraser, I.S., McCarron, G., Hutton, B., Macey, D. Am. J. Obstet. Gynecol. (1987) [Pubmed]
  17. Bcl-2, Fas and caspase 3 expression in endometrium from levonorgestrel implant users with and without breakthrough bleeding. Rogers, P.A., Lederman, F., Plunkett, D., Affandi, B. Hum. Reprod. (2000) [Pubmed]
  18. Optimum dosage of an oral contraceptive. A report from the study of seven combinations of norgestimate and ethinyl estradiol. Lawson, J.S., Yuliano, S.E., Pasquale, S.A., Osterman, J.J. Am. J. Obstet. Gynecol. (1979) [Pubmed]
  19. Oxidative stress, vitamin E and progestin breakthrough bleeding. Subakir, S.B., Abdul Madjid, O., Sabariah, S., Affandi, B. Hum. Reprod. (2000) [Pubmed]
  20. Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. Murphy, P.A., Kern, S.E., Stanczyk, F.Z., Westhoff, C.L. Contraception. (2005) [Pubmed]
  21. Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Smith, S.K., Abel, M.H., Kelly, R.W., Baird, D.T. British journal of obstetrics and gynaecology. (1981) [Pubmed]
  22. Influence of different hormonal regimens on endometrial microvascular density and VEGF expression in women suffering from breakthrough bleeding. Rogers, P.A., Martinez, F., Girling, J.E., Lederman, F., Cann, L., Farrell, E., Tresserra, F., Patel, N. Hum. Reprod. (2005) [Pubmed]
  23. Mechanism of action of the intrauterine contraceptive device: evidence for a specific biochemical deficiency in the endometrium. Seleem, S., Hills, F.A., Salem, H.T., El-Nashar, E.M., Chard, T. Hum. Reprod. (1996) [Pubmed]
  24. Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users. Wonodirekso, S., Hadisaputra, W., Affandi, B., Siregar, B., Rogers, P.A. Hum. Reprod. (1996) [Pubmed]
  25. Decreased ratio of total progesterone to total estradiol receptor levels in endometria of women with adult dysfunctional uterine bleeding. Gorodeski, I.G., Geier, A., Siegal, A., Beery, R., Lunenfeld, B., Langzam, J., Bahari, C.M. Gynecol. Obstet. Invest. (1986) [Pubmed]
  26. Safety of tissue plasminogen activator for acute stroke in menstruating women. Wein, T.H., Hickenbottom, S.L., Morgenstern, L.B., Demchuk, A.M., Grotta, J.C. Stroke (2002) [Pubmed]
  27. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy. Bourdrez, P., Bongers, M.Y., Mol, B.W. Fertil. Steril. (2004) [Pubmed]
  28. Serum lipoperoxide levels in surgical stress of abdominal hysterectomy. Sane, A.S., Chokshi, S.A., Mishra, V.V., Barad, D.P., Shah, V.C., Nagpal, S. Panminerva medica. (1993) [Pubmed]
  29. Hysterectomy in women with cervical stenosis. Surgical indications and pathology. Newman, C., Finan, M.A. The Journal of reproductive medicine. (2003) [Pubmed]
WikiGenes - Universities